Nucleic Acid Extraction Instruments & Reagents Market Insights | Industry Statistics, Emerging Demands, Forecast to 2020-2030

Nucleic Acid Extraction Instruments & Reagents Market: Introduction
According to the report, the global nucleic acid extraction instruments & reagents market was valued at US$ 2.4 Bn in 2019. It is projected to expand at a considerable CAGR from 2020 to 2030. The expansion of the nucleic acid extraction instruments & reagents market can be attributed to the rising prevalence of chronic and infectious diseases, increasing number of patients suffering from COVID-19, rise in awareness and acceptance of personalized medicine and companion diagnostics, and increasing geriatric population. In terms of revenue, North America was a major market for nucleic acid extraction instruments & reagents in 2019. The growth of the market in the region can be attributed to an increase in the demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides for the treatment of cancer, neurological diseases, and chronic kidney diseases. Moreover, rise in the prevalence of lifestyle diseases, increase in healthcare spending, and strong economy are estimated to contribute to North America's dominance of the global nucleic acid extraction instruments & reagents market during the forecast period. These factors are likely to augment the market in North America during the forecast period.

Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80682

Strategic Acquisitions & Collaborations among Key Market Players
Leading players, such as QIAGEN and Thermo Fisher Scientific, focus on enhancing market presence by adopting inorganic growth strategies. This, in turn, enables them to cater to a rise in the demand and consolidate their position in the global nucleic acid extraction instruments & reagents market. In November 2020, QIAGEN entered into a strategic collaboration with BioNTech SE to develop and commercialize a tissue-based companion diagnostic. The test covers a panel of Human papillomavirus (HPV) genotypes, paired with investigational treatment BNT113, to identify patients whose cancers are caused by human papillomavirus (HPV) infections.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=80682

In September 2020, Thermo Fisher Scientific announced a collaboration of Thermo Fisher Precision Medicine Science Center (PMSC) with the University of Nebraska Medical Center and AstraZeneca for the development of novel solutions for unmet needs in clinical biomarker characterization and discovery.
Extraction Kits, Reagents, & Consumables Dominated Global Market
In terms of type, the extraction kits, reagents, & consumables segment is projected to account for a major share of the global nucleic acid extraction instruments & reagents market during the forecast period. Nucleic acid extraction kits are commonly used in the clinical microbiology laboratory. These test kits provide essential requirements for nucleic acid extraction. This is likely to drive the segment during the forecast period. Higher usage of nucleic acid extraction kits, reagents, & consumables further boost the segment.

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80682

Nucleic Acid Extraction Instruments & Reagents Market: Prominent Regions
The global nucleic acid extraction instruments & reagents market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global nucleic acid extraction instruments & reagents market in 2019. The U.S. was a major market for nucleic acid extraction instruments & reagents in the region in 2019. Major share held by the country can be attributable to a large number of patients suffering from chronic and lifestyle diseases, increase in the demand for healthcare products, favorable reimbursement policies, and high per capita healthcare spending in the country. According to the Centers for Medicare & Medicaid Services, per capita healthcare spending of the U.S. was US$ 11,172 in 2018, which is much higher than other countries.
The nucleic acid extraction instruments & reagents market in Asia Pacific is likely to expand at a high CAGR from 2020 to 2030 driven by developing countries such as China and India. Increase in population in the large markets of China and India, rise in average life expectancy, and emergence of a new consumptive middle class with higher demands for healthcare are key factors driving more discoveries of newer products, thereby boosting the demand for pharmaceutical and diagnostic products.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80682

Focus on Strategic Acquisitions and Partnerships by Key Players to Propel Global Market
The global nucleic acid extraction instruments & reagents market is fragmented in terms of the number of players. Key players operating in the global nucleic acid extraction instruments & reagents market are Thermo Fisher Scientific, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Merck KGaA, Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Takara Bio, Inc., Promega Corporation, and QIAGEN.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/ultrasound-devices-market-to-gain-business-prospects-due-to-rise-in-prevalence-of-stroke-cancer-and-heart-disease-says-tmr-301489966.html

https://www.prnewswire.com/news-releases/north-america-lactate-meters-market-to-reach-us-115-2-mn-by-2031--says-tmr-study-301474149.html

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.